Skip to content
Research use only · not for human or veterinary consumption 10 slots open →
Tirzepatide 5mg lyophilised research vial, 99% purity

Specification

Purity>99% (HPLC + MS)
FormLyophilised powder
Supplied asSingle sealed vial
Storage-20 °C, dark, sealed
Reconstituted2–8 °C

Certificate of analysis

Scan the QR code on your vial, or type the batch number, and you get the analytical data for the exact vial you received.

Verify your vial →

Tirzepatide

LY3298176, dual GIP/GLP-1 receptor agonist

A unimolecular dual agonist of the GIP and GLP-1 receptors, and the compound behind the SURMOUNT and SURPASS trial programmes.

Research use only. This compound is supplied for laboratory research. It is not a medicine or supplement, is not approved for human use, and no dosing guidance for humans is offered here or by our team. Handle under appropriate laboratory conditions. Full disclaimer →

What the literature describes

Tirzepatide is a 39-amino-acid synthetic peptide engineered as a single molecule that activates both the GIP and GLP-1 receptors, with a C20 fatty diacid moiety conferring once-weekly pharmacokinetics. The SURMOUNT-1 trial reported substantial and sustained weight reduction over 72 weeks in participants with obesity, and three-year data in participants with obesity and prediabetes reported markedly lower progression to type 2 diabetes versus placebo. Gastrointestinal adverse events were the most common finding and were generally mild-to-moderate and transient.

Available sizes & pricing

Price is per single sealed vial, in USD. Buying several — volume pricing.

Vial strengthPrice
2mg $75.60 Order 2mg
5mg $46 Order 5mg
10mg $66 Order 10mg
15mg $78 Order 15mg
20mg $93 Order 20mg
30mg $118 Order 30mg
40mg $148 Order 40mg
50mg $163 Order 50mg
60mg $208 Order 60mg
80mg $621.60 Order 80mg
100mg $705.60 Order 100mg

Published research

Links open peer-reviewed sources on PubMed. These are provided so you can read the primary literature yourself. Citing a study is not a claim that this compound is safe or effective for any use in humans.

Research areas

Studied in the same area

Retatrutide 5mg lyophilised research vial, 99% purity

Retatrutide

LY3437943, triple GIP/GLP-1/glucagon receptor agonist

A single-molecule triple agonist at the GIP, GLP-1 and glucagon receptors — the most-discussed metabolic research peptide of the current cycle.

5mg10mg15mg20mg30mg50mg+1
$75 from, per vial View
Tesamorelin 2mg lyophilised research vial, 99% purity

Tesamorelin

TH9507, trans-3-hexenoyl-GHRH(1-44)

A stabilised GHRH(1-44) analog and the only GH-axis compound with regulatory approval specifically for reducing visceral adipose tissue.

2mg5mg10mg20mg
$117.60 from, per vial View
MOTS-c 10mg lyophilised research vial, 99% purity

MOTS-c

Mitochondrial ORF of the 12S rRNA type-c

A 16-amino-acid peptide encoded in mitochondrial DNA rather than the nuclear genome — a mitochondrial-derived peptide studied as an exercise mimetic.

10mg40mg
$151.20 from, per vial View
5-AMINO-1MQ 5mg lyophilised research vial, 99% purity

5-AMINO-1MQ

A small-molecule NNMT inhibitor studied in adipocyte metabolism and NAD+ salvage research.

5mg10mg50mg
$53.20 from, per vial View